Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia Ferrantelli

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Vaccines|May 28, 2020
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Claudia Arenaccio, et al.
International Journal of Molecular Sciences|September 4, 2020
Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 TargetingMaria Luisa Fiani, Valeria Barreca, Massimo Sargiacomo, et al.
Vaccines|April 30, 2021
The C-Terminal Domain of Nef<sup>mut</sup> Is Dispensable for the CD8<sup>+</sup> T Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Flavia Ferrantelli, et al.
Cancers|June 2, 2021
Long-Term Antitumor CD8<sup>+</sup> T Cell Immunity Induced by Endogenously Engineered Extracellular VesiclesFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 5, 2019
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLsChiara Chiozzini, Eleonora Olivetta, Massimo Sanchez, et al.
Molecular Biotechnology|September 1, 2018
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and TumorsFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Vaccines|July 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral ProteinFrancesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
Vaccine|December 13, 2002
Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIVFlavia Ferrantelli, Robert A Rasmussen, Regina Hofmann-Lehmann, et al.
Journal of Virology|December 23, 2004
Older rhesus macaque infants are more susceptible to oral infection with simian-human immunodeficiency virus 89.6P than neonatesAgnès-Laurence Chenine, Flavia Ferrantelli, Regina Hofmann-Lehmann, et al.
BMC Infectious Diseases|August 24, 2016
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathologyAurelio Cafaro, Giovanni Piccaro, Giuseppe Altavilla, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Vaccines|May 28, 2020
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Claudia Arenaccio, et al.
International Journal of Molecular Sciences|September 4, 2020
Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 TargetingMaria Luisa Fiani, Valeria Barreca, Massimo Sargiacomo, et al.
Vaccines|April 30, 2021
The C-Terminal Domain of Nef<sup>mut</sup> Is Dispensable for the CD8<sup>+</sup> T Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Flavia Ferrantelli, et al.
Cancers|June 2, 2021
Long-Term Antitumor CD8<sup>+</sup> T Cell Immunity Induced by Endogenously Engineered Extracellular VesiclesFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 5, 2019
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLsChiara Chiozzini, Eleonora Olivetta, Massimo Sanchez, et al.
Molecular Biotechnology|September 1, 2018
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and TumorsFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Vaccines|July 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral ProteinFrancesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
Vaccine|December 13, 2002
Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIVFlavia Ferrantelli, Robert A Rasmussen, Regina Hofmann-Lehmann, et al.
Journal of Virology|December 23, 2004
Older rhesus macaque infants are more susceptible to oral infection with simian-human immunodeficiency virus 89.6P than neonatesAgnès-Laurence Chenine, Flavia Ferrantelli, Regina Hofmann-Lehmann, et al.
BMC Infectious Diseases|August 24, 2016
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathologyAurelio Cafaro, Giovanni Piccaro, Giuseppe Altavilla, et al.
Pageof 5